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Abstract
Background: In Plasmodium falciparum, resistance to chloroquine (CQ) is conferred by a K to T mutation at amino
acid position 76 (K76T) in the P. falciparum CQ transporter (PfCRT). To date, at least 15 pfcrt genotypes, which are
represented by combinations of five amino acids at positions 72-76, have been described in field isolates from
various endemic regions. To identify novel mutant pfcrt genotypes and to reveal the genetic relatedness of pfcrt
genotypes, a large-scale survey over a wide geographic area was performed.
Methods: Sequences for exon 2 in pfcrt, including known polymorphic sites at amino acid positions 72, 74, 75 and
76, were obtained from 256 P. falciparum isolates collected from eight endemic countries in Asia (Bangladesh,
Cambodia, Lao P.D.R., the Philippines and Thailand), Melanesia (Papua New Guinea and Vanuatu) and Africa
(Ghana). A haplotype network was constructed based on six microsatellite markers located -29 kb to 24 kb from
pfcrt in order to examine the genetic relatedness among mutant pfcrt genotypes.
Results: In addition to wild type (CVMNK at positions 72-76), four mutant pfcrt were identified; CVIET, CVIDT,
SVMNTa n dC V M N T (mutated amino acids underlined). Haplotype network revealed that there were only three
mutant pfcrt lineages, originating in Indochina, Philippines and Melanesia. Importantly, the Indochina lineage
contained two mutant pfcrt genotypes, CVIET (n = 95) and CVIDT (n = 14), indicating that CVIDT shares a
common origin with CVIET. Similarly, one major haplotype in the Melanesian lineage contained two pfcrt
genotypes; SVMNT (n = 71) and CVMNT (n = 3). In Africa, all mutant pfcrt genotypes were the CVIET of the
Indochina lineage, probably resulting from the intercontinental migration of CQ resistance from Southeast
Asia.
Conclusions: The number of CQ-mutant lineages observed in this study was identical to that found in previous
studies. This supports the hypothesis that the emergence of novel CQ resistance is rare. However, in the mutant
pfcrt genotypes, amino acid changes at positions 72, 74 and 75 appear to have recently been generated at least
several times, producing distinct pfcrt mutant genotypes. The occurrence of new mutations flanking K76T may
yield stronger resistance to CQ and/or a higher fitness than the original pfcrt mutant.
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The spread of drug-resistant Plasmodium falciparum,
the most virulent malaria parasite, represents a serious
concern for the treatment and control of falciparum
malaria. It is generally believed that the emergence of
drug-resistant P. falciparum is rare and geographically
restricted [1-4]. Clinical resistance to chloroquine (CQ)
was first identified simultaneously in two different geo-
g r a p h i cr e g i o n si nt h el a t e1 9 5 0 s ;S o u t h e a s tA s i a( T h a i -
land-Cambodia border) [5] and South America [6]. CQ
resistance then expanded to neighbouring countries in
the 1960s, and nearly all Southeast Asian countries by
the mid-1970s [4]. In Melanesia, resistance to CQ was
reported in the early 1960s in Indonesian West Papua,
shortly after mass administration of CQ in medicated
table salt [7]. Subsequently, it spread to Papua New Gui-
nea [8] and the Solomon Islands [4] in 1976 and 1980,
respectively. In Africa, CQ resistance was first reported
in the late 1970s in Tanzania [9,10], and it was found to
be have been introduced from Southeast Asia [11].
S i n c et h ed i s c o v e r yo fP. falciparum chloroquine
transporter (PfCRT) as a primary target of CQ resis-
tance [12], reports on the geographic origins and spread
of CQ-resistant P. falciparum have accumulated [1].
PfCRT is localized to the parasite food vacuole and is
known to have > 10 polymorphic amino acid sites [12].
Among these, an amino acid change from Lys (K) to
Thr (T) at position 76 (K76T) plays a decisive role in
conferring resistance to CQ [12]; the mutation greatly
reduces the accumulation of CQ in the parasite food
vacuole by accelerating efflux of CQ [13]. Microsatellite
(MS) analysis flanking the PfCRT gene, pfcrt,h a s
revealed that the geographic origin of CQ resistance is
quite limited, with only four CQ resistant lineages initi-
ally identified: one in Indochina/Africa, one in Melane-
sia, and two in South America (Brazil/Peru and
Ecuador/Colombia) [1]. Subsequently, one distinct CQ-
resistant lineage was discovered in isolates originating in
the Philippines [14].
These CQ resistant lineages harbour one of four
mutant pfcrt genotypes at positions 72-76 (CVIET,
SVMNT, CVMNT and CVMET; mutations underlined),
with the SVMNT genotype being found in Brazil/Peru
and Melanesia lineages [1,14]. In addition, at least 10
mutant pfcrt genotypes have recently been identified in
field isolates from various endemic regions; SVMIT
(Guyana [15]), SVMET (Colombia [16]), SVIET (Indone-
sian Papua [17]), SVMDT (Philippines [18]), CVMET
(Colombia [16]), CVMNN (Indonesia [19]), CVTNT
(Cambodia [20]), CVIDT (Madagascar [21], India [22],
Cambodia [20]), CVMDT (Philippines [18]) and
RVMNT (Guyana [15]). Meanwhile, recovery of CQ sen-
sitivity was reported after the use of CQ was abandoned
in Malawi [23-25]. Similar recovery has also been
reported on Hainan Island, China [26]. This recovery
was thought to be due to the re-introduction of suscep-
tible parasites harbouring a CQ-sensitive pfcrt [27,28],
but a back mutation in pfcrt at position 76 from the
resistant-type amino acid (T) to the sensitive-type
amino acid (K) may also be potentially involved in the
recovery of CQ sensitivity in some endemic areas,
although this has yet to be confirmed.
This possibility can be inferred from the previous
finding of a laboratory-maintained CQ-sensitive P. falci-
parum clone (106/1) originating in Sudan that appar-
ently underwent a back mutation from T to K at
position 76 [12]. It is thus likely that novel pfcrt geno-
types may be identified through surveys of large num-
bers of P. falciparum isolates from diverse geographic
areas. In support of this, recent large-scale surveys of
genotypes of the dihydrofolate reductase gene dhfr,a
target of pyrimethamine, and of the dihydropteroate
gene dhps, a target of sulphadoxine, have identified sev-
eral novel genotypes from wide geographic areas [24,25],
and have provided insights into the evolutionary history
of drug resistance in P. falciparum.
In this study, genotyping of pfcrt and haplotyping of
MS markers flanking pfcrt were performed in P. falci-
parum isolates collected from Asia (Bangladesh, Cambo-
dia, Lao P.D.R., Philippines and Thailand), Melanesia
(Papua New Guinea and Vanuatu), and Africa (Ghana).
Results showed that there were only three CQ-resistant
lineages, all of which were identified previously [1,14].
No evidence of back mutation was observed at position
76. Importantly, however, among pfcrt genotypes having
the K76T mutation, amino acid changes other than K76T
appear to have been recently generated on at least several
occasions, producing novel pfcrt mutant genotypes.
Methods
Study area and samples
Blood samples were obtained from P. falciparum-
infected individuals living in eight malaria endemic
countries as follows.
(1) Thailand: isolates were obtained during a longitu-
dinal study on malaria transmission at a village in Kan-
chanaburi Province located at the western border of
Thailand. Pre-treatment venous blood from a falciparum
malaria-positive villager was obtained for this study
between 2000 and 2003.
(2) Lao P.D.R.: isolates were specifically obtained for
this study. Finger-pricked blood samples were taken in
Napong Village, Boulapha District, Khammouane Pro-
vince, in March 1999.
(3) Cambodia: isolates were obtained from finger-prick
blood samples taken in Chumkiri District, located in the
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2004 [29].
(4) Bangladesh: isolates were obtained from finger-
prick blood samples taken in Bandarban district hospital
from October to December 2007 and six malaria ende-
mic villages; Sultanpur, Chemidalupara, Kyaching ghata
natun para, Saingya daneshpara, Faruqpara and Empu-
para, in Bandarban District, in March 2008 [30].
(5) Philippines: isolates were obtained from pre-treat-
ment venous blood samples taken on Palawan Island,
Palawan Province, in May and October 1997 [31].
(6) Papua New Guinea: isolates were obtained from
finger-prick blood samples taken during in vitro studies
at Wewak General Hospital located in the Wewak Dis-
trict, East Sepik Province, in 2002 and 2003 [32].
(7) Vanuatu: isolates were obtained from finger-prick
blood samples taken on Gaua Island, in February 1997,
Pentecost Island, in February 1998 [33].
(8) Ghana: isolates were obtained from finger-prick
blood samples taken from three villages, Okyereko,
Mpota and Apam, near Winneba, a western coastal
region, in November 2004 [4].
Ethical considerations
Before enrolment, written informed consent was
obtained from all study subjects. In the case of children,
consent was obtained from a parent or legal guardian.
This study was approved by (1) The Institutional Ethics
Committee of the Thai Ministry of Public Health, the
Human Subjects Research Review Board of the United
States Army, (2) The Center of Malariology, Parasitology
and Entomology (CMPE), Lao P.D.R., the Research
Committee of the Ministry of Public Health (MoPH),
Lao P.D.R., (3) The National Center for Parasitology,
Entomology and Malaria Control (CNM), Cambodia, (4)
The Bangladesh Medical Research Council and the local
regulatory body of health in Bandarban, Bangladesh, (5)
The Palawan Provincial Health Office, Philippines, (6)
The National Department of Health Medical Research
Advisory Committee of Papua New Guinea, (7) The
Vanuatu Department of Health, Vanuatu, and (8) The
Ministry of Health/Ghana Health Service, Ghana.
DNA extraction
Finger-prick blood was spotted onto chromatography fil-
ter paper ET31CHR (Whatman, Maidstone, UK) in Lao
P.D.R., Cambodia, Bangladesh, Papua New Guinea,
Vanuatu and Ghana. In Thailand and the Philippines,
venous blood was transferred into heparin-containing
test tubes. Parasite DNA was extracted using QIAamp
DNA mini kits (Qiagen, Hilden, Germany) from a quar-
ter of a dried blood spot or a corresponding amount of
blood (25 μl), in accordance with the manufacturer’s
instructions. The Lao P.D.R. and Bangladesh samples
were extracted using QIAamp DNA mini kits with the
QIAcube™ (Qiagen) tissue protocol.
pfcrt genotyping
The pfcrt gene was amplified by nested PCR using two
sets of primers designed to amplify a region of exon 2
including known polymorphic sites at amino acid posi-
tions 72, 74, 75 and 76. PCR primers were designed
after the sequence of 3D7 clone [GenBank: NC_004328].
Primer sequences and PCR conditions are shown in
Additional file 1. Amplified product (aa 57-120) was
purified using ExoSAP-IT (GE Healthcare UK Ltd.,
Buckinghamshire, UK) and were directly sequenced with
a DYEnamic ET terminator kit in the MegaBACE 1000
DNA sequencer (GE Healthcare UK Ltd.). Data on pfcrt
genotypes previously obtained from Papua New Guinea
were included in the present analysis [32].
Microsatellite haplotyping
Variations in the number of TA repeats located at 0.59
kb, 10.389 kb, 23.576 kb, -2.814 kb and -29.268 kb in
pfcrt and ATT repeats located at 10.389 kb in pfcrt were
measured using PCR protocol previously described with
some modifications (Additional file 2) [34]. Briefly, each
MS marker was amplified by semi-nested PCR using
fluorescent 5’-end labeled primers (Applied Biosystems.,
Foster city, CA, USA) in an ABI 2720 thermal cycler
(Applied Biosystems). Amplified products were analysed
using an ABI 377 DNA sequencer and GeneScan 3.1.2
software with GENESCAN™ 400 HD ROX size stan-
dard (Applied Biosystems), followed by size determina-
tion using a Genotyper 2.0 (Applied Biosystems). When
two or more polymorphisms were detected, these iso-
lates were considered to be mixed infections and
excluded them from further analysis. As it has been well
documented that wild-type parasites show extensive MS
variations due to the lack of selective CQ sweeps [1],
MS haplotypes were determined only for pfcrt mutant
isolates.
Phylogenetic analysis
In order to assess the genetic relationships among CQ-
resistant pfcrt genotypes, a median-joining haplotype
network was constructed based on alleles at the six MS
loci using the Network 4.6 software [35]. Median joining
is a method for constructing genetic networks to iden-
tify the minimum spanning tree by favouring short con-
nections [35].
Results
pfcrt genotypes
Among 263 P. falciparum isolates examined in this
study, pfcrt genotypes were successfully determined in
256 samples. In addition to the wild-type CVMNK
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CVIET (48%), CVIDT (6%), SVMNT (33%) and
CVMNT (1%). Mixed genotypes were observed in four
samples (2%) (Figure 1). In endemic regions of Indo-
china (Thai and Cambodia), South Asia (Bangladesh)
and Africa (Ghana), CVIET was the predominant
mutant genotype, which is consistent with previous stu-
dies [1,11]. One exception was Lao P.D.R., where the
wild genotype and CVIDT were equally predominant,
with CVIET showing a low frequency. In the Philip-
pines, as previously observed [14], SVMNTw a st h e
dominant mutant genotype, and CVMNT was also
found. In Melanesia, only SVMNTw a sf o u n da sa
mutant genotype, as reported previously [36]. We did
not observe any novel mutations at amino acid positions
57-120, other than those known at positions 72, 74, 75
and 76.
Microsatellite haplotypes and network analysis
Among 227 isolates harbouring pfcrt mutant genotypes,
196 samples were successfully determined for MS haplo-
types. In total, 49 MS haplotypes were identified, includ-
ing the three previously known major haplotypes (IC1,
M1 and P1) and those haplotypes similar to IC1, M1 or
P1 (Figure 2). To assess the genetic relatedness of pfcrt
mutants, a haplotype network based on size variations at
all MS markers was constructed. The haplotype network
clearly showed three distinct clusters of pfcrt mutants
(Figure 3). The first lineage (Indochina lineage) con-
sisted of the most prevalent haplotype IC1 (n = 57),
having a combination of alleles of 152-180-182-150-203-
191 at the MS loci of -29.268 kb, -10.833 kb, -2.814 kb,
0.59 kb, 10.389 kb and 23.576 kb, respectively, and
those haplotypes closely related to IC1. Nearly all iso-
lates in this lineage harboured the CVIET genotype.
However, several isolates (IC1, IC5, IC6, IC9 and IC10;
n = 14) contained the CVIDT genotype. This indicates
that this mutant genotype shares a common origin with
CVIET, and that MS haplotype IC1 contained two
mutant pfcrt genotypes. The second lineage (Melanesian
lineage) contained the most prevalent haplotype M1 (n
= 36), having an allele combination of 152-172-182-152-
206-187 and those haplotypes related to M1. All but M2
(CVMNT, n = 3) harboured the SVMNT genotype. This
indicates that MS haplotype M1 also contained two
mutant pfcrt genotypes. In the third lineage (Philippine
lineage), all but one (P2) harboured an allele combina-
tion of 152-170-190-142-200-189 (P1). As previously
Ghana (n = 25)
Bangladesh (n = 40)
Thailand (n = 33)
Cambodia (n = 33)
Philippines (n = 22)
Papua New Guinea
(n = 40)
Vanuatu (n = 31)
Lao PDR (n = 32)
CVIET CVIDT SVMNT CVMNT
CVMNK
Mix
Figure 1 Geographical distribution of pfcrt genotypes in 256 Plasmodium falciparum isolates from eight countries in Asia, Africa and
Melanesia. Capital letters in the box denote amino acid residues at positions 72, 73, 74, 75 and 76, with mutations identified in red. Mixed
genotypes include combinations of CVIE/DT (n = 1), CVMNK/T (n = 1), CVIN/ET (n = 1) and CVIEK/T (n = 1). Gray colour shows a malaria
endemic area.
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b
Indochina  lineage
Microsatellite loci No. of isolates
ID -29.268kb -10.833kb -2.814kb pfcrt genotype 0.59kb 10.389kb23.576k Total THA LAO CAM BAN PHI PNG VAN GHA
IC1 152 180 182 CVIET 150 203 191 47 16 1 18 8 4
152 180 182 CVIDT 150 203 191 10 8 2
IC2 152 184 182 CVIET 150 203 191 2 2
IC3 152 180 182 CVIET 150 203 185 1 1
IC4 152 180 182 CVIET 150 203 179 1 1
IC5 152 180 182 CVIET 150 203 187 2 1 1
152 180 182 CVIDT 150 203 187 1 1
IC6 154 180 182 CVIET 150 203 191 3 1 2
154 180 182 CVIDT 150 203 191 1 1
IC7 152 180 182 CVIET 150 197 191 2 1 1
IC8 152 180 182 CVIET 150 203 193 3 1 1 1
IC9 152 170 182 CVIDT 150 203 191 1 1
IC10 152 180 182 CVIDT 154 203 189 1 1
IC11 152 180 182 CVIET 150 203 199 7 2 5
IC12 152 186 182 CVIET 150 203 197 1 1
IC13 154 180 182 CVIET 150 203 199 2 2
IC14 152 182 182 CVIET 150 200 185 1 1
IC15 152 204 182 CVIET 150 200 187 1 1
IC16 152 180 182 CVIET 150 200 191 5 5
IC17 156 180 182 CVIET 150 203 191 1 1
IC18 152 178 182 CVIET 150 203 199 1 1
IC19 154 170 176 CVIET 150 203 191 1 1
IC20 152 170 176 CVIET 150 203 191 1 1
IC21 152 180 182 CVIET 150 206 195 1 1
IC22 152 180 182 CVIET 150 200 187 1 1
IC23 152 180 182 CVIET 152 203 187 1 1
IC24 152 172 182 CVIET 150 206 187 1 1
IC25 152 180 182 CVIET 148 203 191 1 1
IC26 152 180 182 CVIET 150 206 189 2 2
IC27 152 180 182 CVIET 154 197 197 1 1
IC28 152 180 182 CVIET 154 203 191 1 1
IC29 152 180 182 CVIET 150 212 205 1 1
IC30 154 180 182 CVIET 150 203 201 1 1
IC31 152 180 182 CVIET 148 197 191 1 1
IC32 152 180 182 CVIET 150 191 191 1 1
Melanesian lineage
Microsatellite loci No. of isolates
ID -29.268kb -10.833kb -2.814kb pfcrt genotype 0.59kb 10.389kb23.576k Total THA LAO CAM BAN PHI PNG VAN GHA
M1 152 172 182 SVMNT 152 206 187 36 1 26 9
M2 152 172 176 CVMNT 152 197 187 3 3
M3 152 170 182 SVMNT 152 206 187 1 1
M4 152 170 182 SVMNT 152 197 193 1 1
M5 152 172 182 SVMNT 150 200 185 1 1
M6 154 172 182 SVMNT 152 206 187 11 4 7
M7 154 164 182 SVMNT 152 206 187 1 1
M8 152 172 182 SVMNT 152 206 189 2 2
M9 154 172 182 SVMNT 152 206 185 1 1
M10 154 172 182 SVMNT 152 200 187 1 1
M11 154 172 182 SVMNT 150 194 195 1 1
M12 152 172 184 SVMNT 152 206 187 1 1
M13 152 172 182 SVMNT 152 209 187 10 10
M14 152 172 186 SVMNT 152 206 187 3 3
M15 150 172 182 SVMNT 152 209 187 1 1
Philippine lineage
Microsatellite loci No. of isolates
ID -29.268kb -10.833kb -2.814kb pfcrt genotype 0.59kb 10.389kb23.576k Total THA LAO CAM BAN PHI PNG VAN GHA
P1 152 170 190 SVMNT 142 200 189 12 12
P2 152 170 194 SVMNT 142 200 189 1 1
Figure 2 Microsatellite haplotypes found in 196 chloroquine-resistant P. falciparum isolates from eight countries in Asia, Africa and
Melanesia. The number of TA repeats at each MS locus is shown. MS alleles in the most frequent haplotype are shown in pink (Indochina
lineage), blue (Melanesian lineage) and violet (Philippine lineage). THI; Thailand, LAO; Lao P.D.R., CAM; Cambodia, BAN; Bangladesh, PHI;
Philippines, PNG; Papua New Guinea, VAN; Vanuatu, GHA; Ghana.
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Philippine lineage harboured the SVMNT genotype.
The geographical distribution of the three major
lineages described above was clearly distinctive (Figure
4). The Indochina lineage was widely distributed in
Indochina and Africa, and this is consistent with pre-
vious reports [1,11]. Distribution of the Melanesian line-
age was limited to Papua New Guinea and Vanuatu,
except for four isolates (M1 and M2 found in the Philip-
pines, which probably migrated from Melanesia).
Discussion
The present study using 256 P. falciparum isolates col-
lected from Asia, Melanesia and Africa revealed only
three major lineages of CQ resistance originating in
Indochina, Melanesia and the Philippines. No novel
pfcrt genotype was identified in the present samples col-
lected from large-scale survey. The number of CQ-
mutant lineages observed in this study was identical to
that in two previous studies that analysed 48 laboratory-
adapted CQ-resistant parasite lines [1] and field isolates
in the Philippines [14]. This observation supports the
hypothesis that the emergence of CQ resistance is a rare
event, but the reasons for this rare emergence of CQ
resistance remain to be clarified.
This study also revealed that a single CQ resistance
lineage contained two mutant pfcrt genotypes; the
CVIET and CVIDT genotypes in the Indochina lineage,
and the SVMNT and CVMNT genotypes in the Melane-
sian lineage. Similar findings have been reported pre-
viously; two mutant genotypes (CVIET and CVIES) in a
single CQ-resistant lineage in Africa [11] and two
mutant genotypes (CVMNTa n dC V M ET) in a single
CQ-resistant lineage in South America [1]. In the pre-
sent study, CVIET was the predominant mutant geno-
type in Asia and Africa, except in Lao P.D.R., where the
CVIDT genotype was more prevalent than CVIET. A
high prevalence of the CVIET genotype supports the
notion that this genotype is an ancestral mutant geno-
type in the Indochina lineage, from which the CVIDT
genotype may have evolved. Similarly, the CVMNTg e n -
otype, which was observed in only one case, appears to
be a descendent of the SVMNTg e n o t y p eo ft h eM e l a -
nesian lineage. These additional amino acid changes
may have been generated after the emergence of CQ
resistance, perhaps in the last 30-40 years [37]. Thus, it
is likely that additional amino acid change(s) at positions
72-75 in pfcrt were recently generated in parasites har-
bouring the pfcrt K76T mutation.
T h er o l eo fpfcrt mutations other than K76T remains
to be fully elucidated. They may confer some benefit to
CQ-resistant parasites, e.g., a small effect on CQ toler-
ance or compensation for impaired protein activity after
the acquisition of the critical mutation K76T. For the
conventional anti-malarial drug pyrimethamine, it is
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Figure 3 Haplotype network diagram in Plasmodium falciparum
isolates harbouring pfcrt mutation. Network tree is shown
according to pfcrt genotypes. The haplotype network was
constructed for 196 P. falciparum isolates harbouring pfcrt mutation
comprises 49 microsatellite haplotypes, based on allelic variations in
six microsatellite loci flanking the pfcrt locus (see text for details).
The size of each circle corresponds to the number of samples
sharing the same haplotype, and the length of an edge is
proportional to a variation in repeat number between two
haplotypes. IC; Indochina lineage, M; Melanesian lineage, P;
Philippine lineage.
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Figure 4 Haplotype network diagram in Plasmodium falciparum
isolates harbouring pfcrt mutation. Network tree is shown
according to countries where samples were taken. The haplotype
network was constructed for 196 P. falciparum isolates harbouring
pfcrt mutation comprises 49 microsatellite haplotypes, based on
allelic variations in six microsatellite loci flanking the pfcrt locus (see
text for details). The size of each circle corresponds to the number
of samples sharing the same haplotype, and the length of an edge
is proportional to a variation in repeat number between two
haplotypes. IC; Indochina lineage, M; Melanesian lineage, P;
Philippine lineage.
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progressively accumulate in dhfr; relative IC50 values of
pyrimethamine for mutant dhfr genotypes, as compared
to the wild dhfr genotype, are 35-fold higher in a single
mutant and 1,111-fold higher in a quadruple mutant
(highest resistance dhfr genotype) [38]. Similarly, asso-
ciation between the accumulation of mutations in dhps
and progressive increases of sulphadoxine resistance
have also been reported [39]. Further studies are neces-
sary to clarify the potential association between the
accumulation of additional pfcrt mutations and augmen-
tation of CQ resistance.
The present analysis did not identify a back mutation
at position 76 in pfcrt, as observed in previous studies
[26-28]. However, there remains the possibility that the
back mutation has occurred in geographic areas not stu-
died here. Most of the isolates sampled in the present
s t u d yc a m ef r o mA s i aa n dM e l a n e s i a ,w h e r eC Qi ss t i l l
being used for treatment of Plasmodium vivax. Thus,
the continuous CQ pressure present in Asia and Mela-
nesia may be suppressing the expression of this back
mutation. Further molecular epidemiological studies in
different endemic areas having different histories of CQ
usage may be necessary in order to better understand
the possible back mutation at the critical position 76,
which would indicate the recovery of CQ susceptibility.
The conclusions of the present study are limited to
samples collected from the late 1990s to the mid 2000s
in geographical areas where samples were collected.
Although the intercontinental migration of CQ resis-
tance from Asia to Africa was already accomplished, the
selection and spread of CQ resistance was not homoge-
nously advanced in Asia. In fact, at the time of our sam-
pling, while mutant pfcrt alleles were almost fixed in
Thailand and Cambodia, the selection seemed to be
ongoing in Lao PDR, where nearly half of P. falciparum
still harboured the wild pfcrt genotype.
Conclusions
The present molecular analysis using samples across
Asia, Africa and Melanesia provided two important
insights into CQ resistance in terms of malaria control.
First, the emergence of novel CQ-mutant lineages
among P. falciparum isolates is rare. Second, in isolates
harbouring the K76T mutation, additional mutations in
pfcrt other than K76T have readily been generated (in
the last 30 years). These new mutations may confer
stronger resistance to CQ than the K76T mutant.
Further molecular monitoring of pfcrt genotypes should
provide valuable information with regard to the current
situation of CQ resistance and to the potential emer-
gence of CQ-sensitive P. falciparum isolates in areas
where CQ use has been withdrawn.
Additional material
Additional file 1: PCR conditions for genotyping of pfcrt.
Additional file 2: PCR conditions for determining variations of six
microsatellite loci flanking pfcrt.
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